Compare Snowflake Inc (SNOW) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snowflake Inc vs Health Care Select Sector SPDR Fund — how do they compare? Snowflake Inc trades at $331.51 (market cap $116.95B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Snowflake Inc is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| SNOW | XLV | |
|---|---|---|
Market Cap | $116.95B | — |
Sector | Technology | — |
52-Week High | $356.47 | $175.68 |
52-Week Low | $121.11 | $134.13 |
Enterprise Value | $117.37B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snowflake (SNOW) trades at $335.50, down 0.5% on the day, following a strong earnings-driven rally. The stock exhibits bullish technical signals with support at $331 and resistance at $340. Revenue growth accelerated to 37% year-over-year in Q2 2026, with consistent earnings beats, though profitability remains negative with a net margin of -20.07%. Recent news highlights AI-driven demand boosting product revenue and customer adoption.
Outlook is positive with 81% analyst buy ratings and a $430.10 price target, reflecting optimism around AI data cloud growth. Key risks include high valuation (P/S 21.25), persistent losses, and competitive pressures. Investors should weigh growth potential against profitability challenges and market volatility.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
